The Safety of Ocriplasmin for Symptomatic Vitreomacular Adhesion/Traction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Retina (Philadelphia, Pa.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Safety Profile of Ocriplasmin for the Pharmacologic Treatment of Symptomatic Vitreomacular Adhesion/Traction
Retina (Philadelphia, Pa.) 2015 Jan 29;[EPub Ahead of Print], PK Kaiser, A Kampik, BD Kuppermann, A Girach, S Rizzo, RC SergottFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.